Cargando…

Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0

OBJECTIVE: The objective of this theoretical paper is to identify conceptual solutions for securing, predicting, and improving vaccine production and supply chains. METHOD: The case study, action research, and review method is used with secondary data – publicly available open access data. RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Radanliev, Petar, De Roure, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811889/
https://www.ncbi.nlm.nih.gov/pubmed/36620395
http://dx.doi.org/10.1007/s12553-022-00722-2
_version_ 1784863620267507712
author Radanliev, Petar
De Roure, David
author_facet Radanliev, Petar
De Roure, David
author_sort Radanliev, Petar
collection PubMed
description OBJECTIVE: The objective of this theoretical paper is to identify conceptual solutions for securing, predicting, and improving vaccine production and supply chains. METHOD: The case study, action research, and review method is used with secondary data – publicly available open access data. RESULTS: A set of six algorithmic solutions is presented for resolving vaccine production and supply chain bottlenecks. A different set of algorithmic solutions is presented for forecasting risks during a Disease X event. A new conceptual framework is designed to integrate the emerging solutions in vaccine production and supply chains. The framework is constructed to improve the state-of-the-art by intersecting the previously isolated disciplines of edge computing; cyber-risk analytics; healthcare systems, and AI algorithms. CONCLUSION: For healthcare systems to cope better during a disease X event than during Covid-19, we need multiple highly specific AI algorithms, targeted for solving specific problems. The proposed framework would reduce production and supply chain risk and complexity in a Disease X event.
format Online
Article
Text
id pubmed-9811889
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98118892023-01-04 Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0 Radanliev, Petar De Roure, David Health Technol (Berl) Review Paper OBJECTIVE: The objective of this theoretical paper is to identify conceptual solutions for securing, predicting, and improving vaccine production and supply chains. METHOD: The case study, action research, and review method is used with secondary data – publicly available open access data. RESULTS: A set of six algorithmic solutions is presented for resolving vaccine production and supply chain bottlenecks. A different set of algorithmic solutions is presented for forecasting risks during a Disease X event. A new conceptual framework is designed to integrate the emerging solutions in vaccine production and supply chains. The framework is constructed to improve the state-of-the-art by intersecting the previously isolated disciplines of edge computing; cyber-risk analytics; healthcare systems, and AI algorithms. CONCLUSION: For healthcare systems to cope better during a disease X event than during Covid-19, we need multiple highly specific AI algorithms, targeted for solving specific problems. The proposed framework would reduce production and supply chain risk and complexity in a Disease X event. Springer Berlin Heidelberg 2023-01-04 2023 /pmc/articles/PMC9811889/ /pubmed/36620395 http://dx.doi.org/10.1007/s12553-022-00722-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Paper
Radanliev, Petar
De Roure, David
Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0
title Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0
title_full Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0
title_fullStr Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0
title_full_unstemmed Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0
title_short Disease X vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0
title_sort disease x vaccine production and supply chains: risk assessing healthcare systems operating with artificial intelligence and industry 4.0
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811889/
https://www.ncbi.nlm.nih.gov/pubmed/36620395
http://dx.doi.org/10.1007/s12553-022-00722-2
work_keys_str_mv AT radanlievpetar diseasexvaccineproductionandsupplychainsriskassessinghealthcaresystemsoperatingwithartificialintelligenceandindustry40
AT derouredavid diseasexvaccineproductionandsupplychainsriskassessinghealthcaresystemsoperatingwithartificialintelligenceandindustry40